STOCK TITAN

FIVE9, INC. (FIVN) Financials

FIVN
Trailing 12 months to June 30, 2026
Revenue $1.2B +8.9% YoY
Net Income $59.5M +573.6% YoY
EPS (Diluted) $0.69 +666.7% YoY
Free Cash Flow $209.1M +46.8% YoY
Market Cap $2.8B as of Oct 23, 2026
Price / Sales 2.3x on $1.2B revenue, trailing 12 months to June 30, 2026
Price / Earnings 47.3x on $59.5M net income, trailing 12 months to June 30, 2026
Price / Book 3.6x on $784.8M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 23, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the FIVN SEC filings page.

FIVE9, INC. (FIVN) reported $1.2B in revenue over the twelve months to Jun 30, 2026, up 8.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI FIVN FY2025

Growth is now converting into profit and cash after years when operating costs absorbed most of Five9’s expansion.

Operating cash flow of $226M versus net income of $39M shows that the latest reported profit materially understates cash generation. That conversion coincided with capital expenditures at 2.2% of revenue and 11.0% of operating cash flow, pointing to a business requiring relatively little annual reinvestment to produce cash.

Revenue grew 10.3% while cost of revenue grew 8.1% in FY2025, widening the gross-profit contribution. Operating spending became more restrained, helping operating margin move from -4.9% to 2.5%.

The balance sheet became less liability-heavy: liabilities were 56.1% of assets in FY2025 versus 69.7% in FY2024. The liabilities-to-equity ratio fell from 2.3x to 1.3x, reinforcing that shift.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 52 / 100
Financial Health Score 52/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of FIVE9, INC.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
32

FIVE9, INC. has an operating margin of 2.5%, meaning the company retains $3 of operating profit per $100 of revenue. This results in a moderate score of 32/100, indicating healthy but not exceptional operating efficiency. This is up from -4.9% the prior year.

Growth
70

FIVE9, INC.'s revenue grew 10.3% year-over-year to $1.1B, a solid pace of expansion. This earns a growth score of 70/100.

Leverage
10

FIVE9, INC. has elevated debt relative to equity (D/E of 0.94), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 10/100, reflecting increased financial risk.

Liquidity
89

With a current ratio of 4.51, FIVE9, INC. holds $4.51 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 89/100.

Cash Flow
76

FIVE9, INC. converts 17.5% of revenue into free cash flow ($201.2M). This strong cash generation earns a score of 76/100.

Returns
32

FIVE9, INC.'s ROE of 5.0% shows moderate profitability relative to equity, earning a score of 32/100. This is up from -2.1% the prior year.

Altman Z-Score Grey Zone
2.58

FIVE9, INC. scores 2.58, placing it in the grey zone between 1.81 and 2.99. The largest contribution to the score comes from a market capitalization of $2.8B against total liabilities of $1.0B. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong
7/9

FIVE9, INC. passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
5.74x

For every $1 of reported earnings, FIVE9, INC. generates $5.74 in operating cash flow ($226.2M OCF vs $39.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate
2.05x

FIVE9, INC. earns $2.05 in operating income for every $1 of interest expense ($28.9M vs $14.1M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$312.4M
YoY+10.3%
QoQ+2.3%
5Y CAGR+16.8%
10Y CAGR+23.2%

FIVE9, INC. generated $312.4M in revenue in Q2 2026. This represents an increase of 10.3% from the same quarter a year earlier. Against the prior quarter it is up 2.3%.

EBITDA
$24.1M
YoY+84.2%
QoQ-33.7%
5Y CAGRn/m
10Y CAGRn/m

FIVE9, INC.'s EBITDA was $24.1M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 84.2% from the same quarter a year earlier. Against the prior quarter it is down 33.7%.

Net Income
$3.4M
YoY+191.8%
QoQ-81.7%
5Y CAGRn/m
10Y CAGRn/m

FIVE9, INC. reported $3.4M in net income in Q2 2026. This represents an increase of 191.8% from the same quarter a year earlier. Against the prior quarter it is down 81.7%.

EPS (Diluted)
$0.04
YoY+300.0%
QoQ-81.0%

FIVE9, INC. earned $0.04 per diluted share (EPS) in Q2 2026. This represents an increase of 300.0% from the same quarter a year earlier. Against the prior quarter it is down 81.0%.

Cash & Balance Sheet

Free Cash Flow
$24.5M
YoY-22.5%
QoQ-58.3%
5Y CAGR+179.3%
10Y CAGR+29.2%

FIVE9, INC. generated $24.5M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 22.5% from the same quarter a year earlier. Against the prior quarter it is down 58.3%.

Cash & Debt
$187.3M
YoY-8.8%
QoQ-31.4%
5Y CAGR+1.3%
10Y CAGR+12.5%

FIVE9, INC. held $187.3M in cash against $737.3M in long-term debt as of Q2 2026.

Shares Outstanding
75M
YoY-3.3%
QoQ-2.4%

FIVE9, INC. had 75M shares outstanding in Q2 2026. This represents a decrease of 3.3% from the same quarter a year earlier. Against the prior quarter it is down 2.4%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin
53.4%
YoY-1.5pp
QoQ-2.5pp
5Y change-1.8pp
10Y change-3.5pp

FIVE9, INC.'s gross margin was 53.4% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 1.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.5 percentage points.

Operating Margin
0.6%
YoY+1.2pp
QoQ-5.4pp
5Y change+10.5pp
10Y change+6.3pp

FIVE9, INC.'s operating margin was 0.6% in Q2 2026, reflecting core business profitability. This is up 1.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 5.4 percentage points.

Net Margin
1.1%
YoY+0.7pp
QoQ-5.0pp
5Y change+12.6pp
10Y change+10.0pp

FIVE9, INC.'s net profit margin was 1.1% in Q2 2026, showing the share of revenue converted to profit. This is up 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 5.0 percentage points.

Return on Equity
0.4%
YoY+0.3pp
QoQ-1.8pp
5Y change+10.6pp
10Y change+13.5pp

FIVE9, INC.'s quarterly ROE was 0.4% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is up 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.8 percentage points.

Capital Allocation

R&D Spending
$42.1M
YoY+5.4%
QoQ+6.0%
5Y CAGR+11.3%
10Y CAGR+21.9%

FIVE9, INC. invested $42.1M in research and development in Q2 2026. This represents an increase of 5.4% from the same quarter a year earlier. Against the prior quarter it is up 6.0%.

Share Buybacks
$90.0M
YoYn/m
QoQ+798.9%

FIVE9, INC. spent $90.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 798.9%.

Capital Expenditures
$17.6M
YoY+404.5%
QoQ+234.8%
5Y CAGR+9.4%
10Y CAGR+49.5%

FIVE9, INC. invested $17.6M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 404.5% from the same quarter a year earlier. Against the prior quarter it is up 234.8%.

FIVN Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FIVN quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-KQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-K
Revenue$312.4M+10.3%$305.3M+9.2%$300.3M+7.8%$285.8M+8.2%$283.3M+12.4%$279.7M+13.2%$278.7M+16.6%$264.2M+14.8%
Cost of Revenue$145.7M+13.9%$134.8M+7.0%$133.8M+9.1%$128.6M+5.4%$127.9M+8.0%$126.0M+10.0%$122.7M+9.0%$121.9M+9.8%
Gross Profit$166.7M+7.3%$170.5M+10.9%$166.4M+6.7%$157.3M+10.6%$155.4M+16.3%$153.7M+16.0%$156.0M+23.3%$142.2M+19.5%
R&D Expenses$42.1M+5.4%$39.7M-3.5%$36.1M-13.0%$35.2M-17.1%$39.9M-2.0%$41.1M-1.0%$41.5M+6.7%$42.5M+5.2%
SG&A Expenses$122.7M+4.8%$112.4M-4.8%$110.5M+0.2%$106.0M-8.0%$117.1M+4.2%$118.1M+5.7%$110.3M+3.8%$115.2M+10.4%
Operating Income$2.0Mn/m$18.5Mn/m$19.8M+373.6%$16.0Mn/m-$1.6Mn/m-$5.4Mn/m$4.2Mn/m-$15.4Mn/m
EBITDA$24.1M+84.2%$36.3M+301.0%$36.6M+94.7%$31.8Mn/m$13.1Mn/m$9.1Mn/m$18.8Mn/m-$2.3Mn/m
Interest Expense$3.5M-8.2%$3.1M-23.6%$3.1M-28.5%$3.1M-24.1%$3.8M-2.2%$4.1M+60.3%$4.3M+117.6%$4.1M+106.3%
Income Tax$941K-31.9%$2.2M+1069.0%$3.3Mn/m$643Kn/m$1.4M-58.7%$184K-81.4%-$426K-458.0%-$3.9M-510.6%
Net Income$3.4M+191.8%$18.4M+3096.5%$19.7M+70.3%$18.0Mn/m$1.2Mn/m$576Kn/m$11.6Mn/m-$4.5Mn/m
EPS (Basic)$0.04+100.0%$0.24$0.25+66.7%$0.23n/m$0.02$0.01n/m$0.15n/m-$0.06n/m
EPS (Diluted)$0.04+300.0%$0.21$0.23+76.9%$0.21n/m$0.01$0.01n/m$0.13n/m-$0.06n/m
Diluted Shares (Avg)85M-3.4%86M87M-1.8%87M+16.6%89M89M+21.5%89M+21.6%75M+3.5%

FIVN Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FIVN quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-KQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-K
Total Assets$1.8B+7.3%$1.9B-10.7%$1.8B-12.7%$1.8B-11.9%$1.7B-10.8%$2.1B+11.7%$2.1B+37.2%$2.0B+37.9%
Current Assets$951.3M+6.4%$1.0B-21.9%$959.7M-23.1%$949.4M-21.2%$894.2M-32.4%$1.3B-0.1%$1.2B+35.1%$1.2B+35.2%
Cash & Equivalents$187.3M-8.8%$273.0M-26.3%$232.1M-36.0%$193.4M-33.5%$205.5M+16.9%$370.3M+54.2%$362.5M+153.2%$291.0M+127.6%
Short-Term Investments$466.8M+8.4%$450.9M-32.8%$464.8M-27.8%$482.7M-28.6%$430.4M-53.8%$671.4M-20.4%$643.4M+9.6%$675.7M+18.0%
Accounts Receivable$141.5M+10.7%$136.5M+15.1%$131.0M+13.7%$138.5M+18.9%$127.8M+22.5%$118.6M+15.0%$115.2M+18.2%$116.4M+23.3%
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Goodwill$366.3M-0.1%$366.3M-0.1%$366.3M+0.2%$366.3M+0.2%$366.7M+61.3%$366.7M+61.3%$365.4M+60.7%$365.4M+60.7%
Total Liabilities$1.0B+5.9%$1.0B-27.4%$1.0B-29.7%$993.1M-31.1%$987.5M-28.7%$1.4B+2.7%$1.4B+49.4%$1.4B+49.8%
Current Liabilities$229.3M+13.7%$222.8M-65.1%$213.0M-66.8%$205.7M-68.4%$201.6M-67.2%$638.9M+248.1%$641.7M+283.8%$650.2M+278.1%
Non-Current Liabilities$816.0M+3.8%$812.9M+3.3%$791.2M+0.5%$787.4M-0.6%$785.9M+2.1%$786.7M-34.7%$787.3M-0.2%$792.1M+0.2%
Long-Term Debt$737.3M+0.5%$736.4M+0.5%$735.5M+0.5%$734.6M+0.5%$733.6M+0.5%$732.7M-36.9%$731.9M-1.4%$730.9M-1.4%
Total Equity$784.8M+9.4%$829.6M+24.9%$785.8M+26.3%$775.3M+37.1%$717.4M+36.4%$664.3M+37.4%$622.2M+15.6%$565.6M+14.5%
Retained Earnings-$356.4Mn/m-$359.8Mn/m-$378.2Mn/m-$397.9Mn/m-$415.9Mn/m-$417.1Mn/m-$417.6Mn/m-$429.2Mn/m

Not reported in any period shown, so not listed: Inventory.

FIVN Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FIVN quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-KQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-K
Operating Cash Flow$42.1M+20.0%$63.9M+32.1%$83.6M+67.8%$59.2M+44.0%$35.1M+76.4%$48.4M+49.6%$49.8M+36.3%$41.1M+11.1%
Depreciation & Amortization$22.1M+51.0%$17.8M+23.1%$16.9M+15.1%$15.8M+20.0%$14.6M+13.2%$14.5M+18.9%$14.6M+12.9%$13.1M+5.3%
Stock-Based Compensation$33.0M-21.2%$32.7M-16.8%$33.6M-12.5%$33.3M-15.7%$41.9M-4.1%$39.2M-12.2%$38.4M-22.4%$39.6M-24.8%
Capital Expenditures$17.6M+404.5%$5.3M+11.5%$6.2M-32.8%$10.5M-26.9%$3.5M-48.4%$4.7M-60.5%$9.3M-17.7%$14.4M+335.7%
Free Cash Flow$24.5M-22.5%$58.7M+34.3%$77.3M+90.8%$48.7M+82.0%$31.6M+140.8%$43.7M+114.0%$40.5M+60.5%$26.7M-20.7%
Investing Cash Flow-$42.3M-118.5%-$146Kn/m$3.2M-82.7%-$71.9M-195.4%$229.2Mn/m-$38.1Mn/m$18.2Mn/m$75.4Mn/m
Financing Cash Flow-$85.4Mn/m-$22.8Mn/m-$48.0M-1543.3%$576Kn/m-$429.0M-4857.8%-$2.2M-100.7%$3.3M-5.8%-$1.0M-400.0%
Share Buybacks$90.0Mn/m$10.0Mn/mN/AN/A$0$0N/AN/A

Not reported in any period shown, so not listed: Dividends Paid.

FIVN Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FIVN quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-KQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-K
Gross Margin53.4%-1.5pp55.9%+0.9pp55.4%-0.5pp55.0%+1.2pp54.9%+1.8pp55.0%+1.3pp56.0%+3.0pp53.8%+2.1pp
Operating Margin0.6%+1.2pp6.1%+8.0pp6.6%+5.1pp5.6%+11.4pp-0.5%+7.1pp-1.9%+6.4pp1.5%+9.3pp-5.8%+5.3pp
Net Margin1.1%+0.7pp6.0%+5.8pp6.6%+2.4pp6.3%+8.0pp0.4%+5.5pp0.2%+3.1pp4.2%+9.3pp-1.7%+7.2pp
Return on Equity0.4%+0.3pp2.2%+2.1pp2.5%+0.7pp2.3%+3.1pp0.2%+2.6pp0.1%+1.6pp1.9%+4.2pp-0.8%+3.3pp
Return on Assets0.2%+0.1pp1.0%+1.0pp1.1%+0.5pp1.0%+1.2pp0.1%+0.7pp0.0%+0.4pp0.6%+1.4pp-0.2%+1.2pp
Current Ratio4.15-0.3x4.51+2.5x4.51+2.6x4.61+2.8x4.44+2.3x2.02-5.0x1.95-3.6x1.85-3.3x
Debt-to-Equity0.94-0.1x0.89-0.2x0.94-0.2x0.95-0.3x1.02-0.4x1.10-1.3x1.18-0.2x1.29-0.2x
Liabilities-to-Equity1.330.0x1.25-0.9x1.28-1.0x1.28-1.3x1.38-1.3x2.15-0.7x2.30+0.5x2.55+0.6x
Asset Turnover0.170.0x0.160.0x0.170.0x0.160.0x0.170.0x0.130.0x0.140.0x0.130.0x
FCF Margin7.8%-3.3pp19.2%+3.6pp25.8%+11.2pp17.0%+6.9pp11.1%+5.9pp15.6%+7.3pp14.5%+4.0pp10.1%-4.5pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
FIVE9, INC. FIVN FY2025 $1.1B $39.4M 3.4% $2.8B 52/100
TERADATA CORPORATION TDC FY2025 $1.7B $130.0M 7.8% $3.2B 61/100
Appian Corporation APPN FY2025 $726.9M $1.2M 0.2% $3.7B 31/100
C3.ai, Inc. AI FY2026 $250.3M -$470.4M N/A $2.0B 51/100
EVERTEC, INC. EVTC FY2025 $931.8M $141.6M 15.2% $1.9B 64/100

Frequently Asked Questions

What is FIVE9, INC.'s annual revenue?

FIVE9, INC. (FIVN) reported $1.1B in total revenue for fiscal year 2025. This represents a 10.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is FIVE9, INC.'s revenue growing?

FIVE9, INC. (FIVN) revenue grew by 10.3% year-over-year, from $1.0B to $1.1B in fiscal year 2025.

Is FIVE9, INC. profitable?

Yes, FIVE9, INC. (FIVN) reported a net income of $59.5M over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net income of $39.4M, with a net profit margin of 3.4%.

FIVE9, INC. (FIVN) reported diluted earnings per share of $0.45 for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

FIVE9, INC. (FIVN) had EBITDA of $90.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, FIVE9, INC. (FIVN) had $232.1M in cash and equivalents against $735.5M in long-term debt.

FIVE9, INC. (FIVN) had a gross margin of 55.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

FIVE9, INC. (FIVN) had an operating margin of 2.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

FIVE9, INC. (FIVN) had a net profit margin of 3.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

FIVE9, INC. (FIVN) has a return on equity of 5.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

FIVE9, INC. (FIVN) generated $201.2M in free cash flow during fiscal year 2025. This represents a 99.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

FIVE9, INC. (FIVN) generated $226.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

FIVE9, INC. (FIVN) had $1.8B in total assets as of fiscal year 2025, including both current and long-term assets.

FIVE9, INC. (FIVN) invested $25.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

FIVE9, INC. (FIVN) invested $152.3M in research and development during fiscal year 2025.

Yes, FIVE9, INC. (FIVN) spent $50.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

FIVE9, INC. (FIVN) had 76M shares outstanding as of fiscal year 2025.

FIVE9, INC. (FIVN) had a current ratio of 4.51 as of fiscal year 2025, which is generally considered healthy.

FIVE9, INC. (FIVN) had a debt-to-equity ratio of 0.94 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

FIVE9, INC. (FIVN) had a liabilities-to-equity ratio of 1.28 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

FIVE9, INC. (FIVN) had a return on assets of 2.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

FIVE9, INC. (FIVN) trades at 47.3x earnings, its market capitalization divided by $59.5M net income, trailing 12 months to June 30, 2026. The market capitalization is $2.8B as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

FIVE9, INC. (FIVN) trades at 2.3x sales, its market capitalization divided by $1.2B revenue, trailing 12 months to June 30, 2026. The market capitalization is $2.8B as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

FIVE9, INC. (FIVN) has an Altman Z-Score of 2.58, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

FIVE9, INC. (FIVN) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

FIVE9, INC. (FIVN) has an earnings quality ratio of 5.74x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

FIVE9, INC. (FIVN) has an interest coverage ratio of 2.05x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

FIVE9, INC. (FIVN) scores 52 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top